CEO Gary Guthart quelled concerns of reflexive pricing, with production and manufacturing optimisation a priority instead.

Barclays lowered the firm’s price target on Intuitive Surgical (ISRG) to $635 from $684 and keeps an Overweight rating on the shares following ...

Intuitive Surgical is the world’s leading robotic surgery company, and it has a solid earnings track record. The company ...

Intuitive Surgical stock reversed bullishly Wednesday after investors digested the robotic surgery titan's conservative ...

Surgical is warning that President Donald Trump's import taxes and retaliation from trade partners could have a significant ...

CFO Jamie Samath cautioned that the trade environment, financial pressures on hospitals and macroeconomic risks could extend ...

Intuitive (the "Company") (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today ...

In a report released yesterday, Ryan Zimmerman from BTIG maintained a Buy rating on Intuitive Surgical (ISRG – Research Report), with a price ...

Bruker Corporation today announced the launch of the nVista 2P miniature, two-photon microscope, a groundbreaking addition to ...